Home > > > Report Detail

Global RNA Based Therapeutics Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 86

As the global economy mends, the 2021 growth of RNA Based Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global RNA Based Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global RNA Based Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States RNA Based Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global RNA Based Therapeutics market, reaching US$ million by the year 2028. As for the Europe RNA Based Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main RNA Based Therapeutics players cover ISIS pharmaceuticals (USA), Quark Pharmaceuticals (USA), Alnylam Pharmaceuticals (USA), and Dicerna Pharmaceuticals (USA), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of RNA Based Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- qRT-PCR

- RNA Interference (RNAi) Technologies

- RNA Antisense

- Inhibition

- Microarrays

- Labeling

- Purification

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Cardiovascular

- Kidney Diseases

- Oncology

- Infectious Diseases

- Metabolic Disorders

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- ISIS pharmaceuticals (USA)

- Quark Pharmaceuticals (USA)

- Alnylam Pharmaceuticals (USA)

- Dicerna Pharmaceuticals (USA)

- Tekmira Pharmaceuticals Corp. (Canada)

- Benitec Biopharma Limited (Australia)

- Genzyme Corporation (USA)

- Silence Therapeutics PLC (UK)

- Cenix BioScience GmbH (Germany)

Global RNA Based Therapeutics Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Based Therapeutics Market Size 2017-2028
2.1.2 RNA Based Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 RNA Based Therapeutics Segment by Type
2.2.1 qRT-PCR
2.2.2 RNA Interference (RNAi) Technologies
2.2.3 RNA Antisense
2.2.4 Inhibition
2.2.5 Microarrays
2.2.6 Labeling
2.2.7 Purification
2.3 RNA Based Therapeutics Market Size by Type
2.3.1 RNA Based Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global RNA Based Therapeutics Market Size Market Share by Type (2017-2022)
2.4 RNA Based Therapeutics Segment by Application
2.4.1 Cardiovascular
2.4.2 Kidney Diseases
2.4.3 Oncology
2.4.4 Infectious Diseases
2.4.5 Metabolic Disorders
2.5 RNA Based Therapeutics Market Size by Application
2.5.1 RNA Based Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global RNA Based Therapeutics Market Size Market Share by Application (2017-2022)
3 RNA Based Therapeutics Market Size by Player
3.1 RNA Based Therapeutics Market Size Market Share by Players
3.1.1 Global RNA Based Therapeutics Revenue by Players (2020-2022)
3.1.2 Global RNA Based Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global RNA Based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA Based Therapeutics by Regions
4.1 RNA Based Therapeutics Market Size by Regions (2017-2022)
4.2 Americas RNA Based Therapeutics Market Size Growth (2017-2022)
4.3 APAC RNA Based Therapeutics Market Size Growth (2017-2022)
4.4 Europe RNA Based Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa RNA Based Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas RNA Based Therapeutics Market Size by Country (2017-2022)
5.2 Americas RNA Based Therapeutics Market Size by Type (2017-2022)
5.3 Americas RNA Based Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Based Therapeutics Market Size by Region (2017-2022)
6.2 APAC RNA Based Therapeutics Market Size by Type (2017-2022)
6.3 APAC RNA Based Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA Based Therapeutics by Country (2017-2022)
7.2 Europe RNA Based Therapeutics Market Size by Type (2017-2022)
7.3 Europe RNA Based Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Based Therapeutics by Region (2017-2022)
8.2 Middle East & Africa RNA Based Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa RNA Based Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA Based Therapeutics Market Forecast
10.1 Global RNA Based Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global RNA Based Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas RNA Based Therapeutics Forecast
10.1.3 APAC RNA Based Therapeutics Forecast
10.1.4 Europe RNA Based Therapeutics Forecast
10.1.5 Middle East & Africa RNA Based Therapeutics Forecast
10.2 Americas RNA Based Therapeutics Forecast by Country (2023-2028)
10.2.1 United States RNA Based Therapeutics Market Forecast
10.2.2 Canada RNA Based Therapeutics Market Forecast
10.2.3 Mexico RNA Based Therapeutics Market Forecast
10.2.4 Brazil RNA Based Therapeutics Market Forecast
10.3 APAC RNA Based Therapeutics Forecast by Region (2023-2028)
10.3.1 China RNA Based Therapeutics Market Forecast
10.3.2 Japan RNA Based Therapeutics Market Forecast
10.3.3 Korea RNA Based Therapeutics Market Forecast
10.3.4 Southeast Asia RNA Based Therapeutics Market Forecast
10.3.5 India RNA Based Therapeutics Market Forecast
10.3.6 Australia RNA Based Therapeutics Market Forecast
10.4 Europe RNA Based Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany RNA Based Therapeutics Market Forecast
10.4.2 France RNA Based Therapeutics Market Forecast
10.4.3 UK RNA Based Therapeutics Market Forecast
10.4.4 Italy RNA Based Therapeutics Market Forecast
10.4.5 Russia RNA Based Therapeutics Market Forecast
10.5 Middle East & Africa RNA Based Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt RNA Based Therapeutics Market Forecast
10.5.2 South Africa RNA Based Therapeutics Market Forecast
10.5.3 Israel RNA Based Therapeutics Market Forecast
10.5.4 Turkey RNA Based Therapeutics Market Forecast
10.5.5 GCC Countries RNA Based Therapeutics Market Forecast
10.6 Global RNA Based Therapeutics Forecast by Type (2023-2028)
10.7 Global RNA Based Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 ISIS pharmaceuticals (USA)
11.1.1 ISIS pharmaceuticals (USA) Company Information
11.1.2 ISIS pharmaceuticals (USA) RNA Based Therapeutics Product Offered
11.1.3 ISIS pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 ISIS pharmaceuticals (USA) Main Business Overview
11.1.5 ISIS pharmaceuticals (USA) Latest Developments
11.2 Quark Pharmaceuticals (USA)
11.2.1 Quark Pharmaceuticals (USA) Company Information
11.2.2 Quark Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
11.2.3 Quark Pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Quark Pharmaceuticals (USA) Main Business Overview
11.2.5 Quark Pharmaceuticals (USA) Latest Developments
11.3 Alnylam Pharmaceuticals (USA)
11.3.1 Alnylam Pharmaceuticals (USA) Company Information
11.3.2 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
11.3.3 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Alnylam Pharmaceuticals (USA) Main Business Overview
11.3.5 Alnylam Pharmaceuticals (USA) Latest Developments
11.4 Dicerna Pharmaceuticals (USA)
11.4.1 Dicerna Pharmaceuticals (USA) Company Information
11.4.2 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
11.4.3 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Dicerna Pharmaceuticals (USA) Main Business Overview
11.4.5 Dicerna Pharmaceuticals (USA) Latest Developments
11.5 Tekmira Pharmaceuticals Corp. (Canada)
11.5.1 Tekmira Pharmaceuticals Corp. (Canada) Company Information
11.5.2 Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Product Offered
11.5.3 Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Tekmira Pharmaceuticals Corp. (Canada) Main Business Overview
11.5.5 Tekmira Pharmaceuticals Corp. (Canada) Latest Developments
11.6 Benitec Biopharma Limited (Australia)
11.6.1 Benitec Biopharma Limited (Australia) Company Information
11.6.2 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product Offered
11.6.3 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Benitec Biopharma Limited (Australia) Main Business Overview
11.6.5 Benitec Biopharma Limited (Australia) Latest Developments
11.7 Genzyme Corporation (USA)
11.7.1 Genzyme Corporation (USA) Company Information
11.7.2 Genzyme Corporation (USA) RNA Based Therapeutics Product Offered
11.7.3 Genzyme Corporation (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genzyme Corporation (USA) Main Business Overview
11.7.5 Genzyme Corporation (USA) Latest Developments
11.8 Silence Therapeutics PLC (UK)
11.8.1 Silence Therapeutics PLC (UK) Company Information
11.8.2 Silence Therapeutics PLC (UK) RNA Based Therapeutics Product Offered
11.8.3 Silence Therapeutics PLC (UK) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Silence Therapeutics PLC (UK) Main Business Overview
11.8.5 Silence Therapeutics PLC (UK) Latest Developments
11.9 Cenix BioScience GmbH (Germany)
11.9.1 Cenix BioScience GmbH (Germany) Company Information
11.9.2 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product Offered
11.9.3 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cenix BioScience GmbH (Germany) Main Business Overview
11.9.5 Cenix BioScience GmbH (Germany) Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. RNA Based Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of qRT-PCR
Table 3. Major Players of RNA Interference (RNAi) Technologies
Table 4. Major Players of RNA Antisense
Table 5. Major Players of Inhibition
Table 6. Major Players of Microarrays
Table 7. Major Players of Labeling
Table 8. Major Players of Purification
Table 9. RNA Based Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global RNA Based Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global RNA Based Therapeutics Market Size Market Share by Type (2017-2022)
Table 12. RNA Based Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global RNA Based Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global RNA Based Therapeutics Market Size Market Share by Application (2017-2022)
Table 15. Global RNA Based Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global RNA Based Therapeutics Revenue Market Share by Player (2020-2022)
Table 17. RNA Based Therapeutics Key Players Head office and Products Offered
Table 18. RNA Based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global RNA Based Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global RNA Based Therapeutics Market Size Market Share by Regions (2017-2022)
Table 23. Americas RNA Based Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas RNA Based Therapeutics Market Size Market Share by Country (2017-2022)
Table 25. Americas RNA Based Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas RNA Based Therapeutics Market Size Market Share by Type (2017-2022)
Table 27. Americas RNA Based Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas RNA Based Therapeutics Market Size Market Share by Application (2017-2022)
Table 29. APAC RNA Based Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC RNA Based Therapeutics Market Size Market Share by Region (2017-2022)
Table 31. APAC RNA Based Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC RNA Based Therapeutics Market Size Market Share by Type (2017-2022)
Table 33. APAC RNA Based Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC RNA Based Therapeutics Market Size Market Share by Application (2017-2022)
Table 35. Europe RNA Based Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe RNA Based Therapeutics Market Size Market Share by Country (2017-2022)
Table 37. Europe RNA Based Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe RNA Based Therapeutics Market Size Market Share by Type (2017-2022)
Table 39. Europe RNA Based Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe RNA Based Therapeutics Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa RNA Based Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa RNA Based Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa RNA Based Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of RNA Based Therapeutics
Table 48. Key Market Challenges & Risks of RNA Based Therapeutics
Table 49. Key Industry Trends of RNA Based Therapeutics
Table 50. Global RNA Based Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global RNA Based Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global RNA Based Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global RNA Based Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global RNA Based Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global RNA Based Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 56. ISIS pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 57. ISIS pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 58. ISIS pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. ISIS pharmaceuticals (USA) Main Business
Table 60. ISIS pharmaceuticals (USA) Latest Developments
Table 61. Quark Pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 62. Quark Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 63. Quark Pharmaceuticals (USA) Main Business
Table 64. Quark Pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Quark Pharmaceuticals (USA) Latest Developments
Table 66. Alnylam Pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 67. Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 68. Alnylam Pharmaceuticals (USA) Main Business
Table 69. Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Alnylam Pharmaceuticals (USA) Latest Developments
Table 71. Dicerna Pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 72. Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 73. Dicerna Pharmaceuticals (USA) Main Business
Table 74. Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Dicerna Pharmaceuticals (USA) Latest Developments
Table 76. Tekmira Pharmaceuticals Corp. (Canada) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 77. Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Product Offered
Table 78. Tekmira Pharmaceuticals Corp. (Canada) Main Business
Table 79. Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Tekmira Pharmaceuticals Corp. (Canada) Latest Developments
Table 81. Benitec Biopharma Limited (Australia) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 82. Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product Offered
Table 83. Benitec Biopharma Limited (Australia) Main Business
Table 84. Benitec Biopharma Limited (Australia) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Benitec Biopharma Limited (Australia) Latest Developments
Table 86. Genzyme Corporation (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 87. Genzyme Corporation (USA) RNA Based Therapeutics Product Offered
Table 88. Genzyme Corporation (USA) Main Business
Table 89. Genzyme Corporation (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Genzyme Corporation (USA) Latest Developments
Table 91. Silence Therapeutics PLC (UK) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 92. Silence Therapeutics PLC (UK) RNA Based Therapeutics Product Offered
Table 93. Silence Therapeutics PLC (UK) Main Business
Table 94. Silence Therapeutics PLC (UK) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Silence Therapeutics PLC (UK) Latest Developments
Table 96. Cenix BioScience GmbH (Germany) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 97. Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product Offered
Table 98. Cenix BioScience GmbH (Germany) Main Business
Table 99. Cenix BioScience GmbH (Germany) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Cenix BioScience GmbH (Germany) Latest Developments
List of Figures
Figure 1. RNA Based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA Based Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global RNA Based Therapeutics Market Size Market Share by Type in 2021
Figure 7. RNA Based Therapeutics in Cardiovascular
Figure 8. Global RNA Based Therapeutics Market: Cardiovascular (2017-2022) & ($ Millions)
Figure 9. RNA Based Therapeutics in Kidney Diseases
Figure 10. Global RNA Based Therapeutics Market: Kidney Diseases (2017-2022) & ($ Millions)
Figure 11. RNA Based Therapeutics in Oncology
Figure 12. Global RNA Based Therapeutics Market: Oncology (2017-2022) & ($ Millions)
Figure 13. RNA Based Therapeutics in Infectious Diseases
Figure 14. Global RNA Based Therapeutics Market: Infectious Diseases (2017-2022) & ($ Millions)
Figure 15. RNA Based Therapeutics in Metabolic Disorders
Figure 16. Global RNA Based Therapeutics Market: Metabolic Disorders (2017-2022) & ($ Millions)
Figure 17. Global RNA Based Therapeutics Market Size Market Share by Application in 2021
Figure 18. Global RNA Based Therapeutics Revenue Market Share by Player in 2021
Figure 19. Global RNA Based Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas RNA Based Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. APAC RNA Based Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Europe RNA Based Therapeutics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa RNA Based Therapeutics Market Size 2017-2022 ($ Millions)
Figure 24. Americas RNA Based Therapeutics Value Market Share by Country in 2021
Figure 25. Americas RNA Based Therapeutics Consumption Market Share by Type in 2021
Figure 26. Americas RNA Based Therapeutics Market Size Market Share by Application in 2021
Figure 27. United States RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC RNA Based Therapeutics Market Size Market Share by Region in 2021
Figure 32. APAC RNA Based Therapeutics Market Size Market Share by Application in 2021
Figure 33. China RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe RNA Based Therapeutics Market Size Market Share by Country in 2021
Figure 40. Europe RNA Based Therapeutics Market Size Market Share by Type in 2021
Figure 41. Europe RNA Based Therapeutics Market Size Market Share by Application in 2021
Figure 42. Germany RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Application in 2021
Figure 50. Egypt RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country RNA Based Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. APAC RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Europe RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. United States RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Canada RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. China RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Japan RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Korea RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. India RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Australia RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Germany RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. France RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. UK RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Italy RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Russia RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Spain RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Israel RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries RNA Based Therapeutics Market Size 2023-2028 ($ Millions)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs